Fut, nem toborozFázis nélkül
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
A legfontosabb adatok
- Ki végzi
- Cochlear
- Hol
- Chapel Hill, Englewood, Iowa City, New York, Palo Alto és Seattle (Egyesült Államok)Mind a 6 helyszín megnézése
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 60 fő, tervezett
- Kezdés
- 2022. aug. 19.
- Várható befejezés
- 2027. jún.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- The Cochlear™ Nucleus® Cochlear Implant (CI) System
- A regiszteradat frissítve
- 2026. szeptember 30.
Ki vehet részt
- Életkor
- 5 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 18 feltétel megnézéseKevesebb
Ki vehet részt
- Individuals 18 years or older (Group A); Ear to be Implanted:; Severe sensorineural hearing loss (HL) defined as: Pure-tone average at 0.5, 1, 2, 4 kHz >80 dB HL ; Aided Consonant-Nucleus-Consonant Test (CNC) score ≤5% and; Normal Hearing Ear:; Normal or near normal hearing defined as an average of (0.5, 1, 2, 4kHz) ≤ 30 dB HL
- Children 5 years to 17 years, 11 months (Group B); Ear to be Implanted:; Severe sensorineural HL defined as: Pure-tone average at 0.5, 1, 2, 4 kHz >80 dB HL; Aided CNC score ≤5% and; Normal Hearing Ear:; Normal or near normal hearing defined as an average of (0.5, 1, 2, 4kHz) ≤ 30 dB HL
- Previous experience with a current conventional treatment option for unilateral [SSD] HL (HA, bone-conduction device, or CROS technology), if no previous experience a minimum trial period of two weeks is required
- English spoken as a primary language
- Willing and able to provide written informed consent
Ki nem vehet részt
- Previous cochlear implantation
- Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device
- Active / chronic middle-ear infection; conductive HL in either ear
- Medical or psychological conditions that contraindicate undergoing surgery as determined by the Investigator
- Duration of profound sensorineural HL >10 years per self-report
- Ossification, abnormal cochlear nerve or any other cochlear anomaly that might prevent complete insertion of the electrode array
- Hearing loss of neural or central origin, including auditory neuropathy
- Unrealistic expectations on the part of the participant/family, regarding the possible benefits, risks, and limitations that are inherent as determined by the Investigator
- Evidence of and/or suspected cognitive or developmental concern
- Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
- Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child or sibling
- Cochlear employees or employees of Contract Research Organizations (CROs) or contractors engaged by Cochlear for the purposes of this investigation
- Pregnant or breastfeeding women
Helyszínek itt: Egyesült Államok
- University of North CarolinaChapel Hill, Egyesült Államok
- Rocky Mountain Ear CenterEnglewood, Egyesült Államok
- University of IowaIowa City, Egyesült Államok
- New York Eye and Ear InfirmaryNew York, Egyesült Államok
- Stanford UniversityPalo Alto, Egyesült Államok
- Virginia Mason Medical CenterSeattle, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.
A vizsgálat csoportja
- Children and adults with unilateral hearing loss/single-sided deafnessEgyéb csoport
Kezelés: The Cochlear™ Nucleus® Cochlear Implant (CI) System
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Post-approval, Prospective, Nonrandomized, Single-arm Multicenter Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
- A regiszteradat frissítve
- 2026. szeptember 30.